FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
4 hours ago
0
1
Pathological Conditions, Signs and Symptoms: News and Research on Neurologic Manifestations
MeSH tree: C23.888.592
Researchers uncover possible cause of muscle pain from widely used cholesterol medication
Millions of people rely on statins, a medication used to lower cholesterol and reduce the risk of heart attack and stroke. But for some, the drugs come with an unwelcome trade-off: muscle pain, weakness and exercise intolerance ...
23 hours ago
0
61
Researchers discover molecular 'switch' that simultaneously manages touch and pain
A research team led by Prof. Hyosang Lee of the Department of Brain Sciences at DGIST has identified TWIK-1, a type of potassium channel expressed in the spinal cord and peripheral sensory neurons of the somatosensory system, ...
Jul 6, 2026
0
3
125 passengers and crew hit with highly contagious stomach virus on cruise from San Francisco
More than 120 passengers and crew members on a Princess Cruises ship that docked in San Francisco on Thursday were infected with a stomach virus while on their voyage, federal health officials said.
Jul 3, 2026
0
6
Shared neurodevelopmental spectrum could link ADHD, autism and dyslexia to later outcomes
A paper published in Molecular Psychiatry, led by researchers from Queen Mary University of London and Royal Holloway, University of London, challenges the way we think about neurodevelopmental conditions.
Jul 2, 2026
0
9
Persistent vision and hearing health gap for Indigenous Australians
A nationally representative Australian study published in The Lancet Global Health has found that vision impairment remains almost three times more prevalent among Indigenous Australians ages 50 and older than non-Indigenous ...
Jul 2, 2026
0
2
Hearing loss in diabetes patients a 'hidden epidemic'
Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health ...
Jul 2, 2026
0
4
Study identifies new brain targets for individualized epilepsy treatment
Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.
Jul 1, 2026
0
4
Cognitive flexibility problems may arise months before memory impairment in Alzheimer's
When most people think about Alzheimer's disease, memory loss is usually the first thing that comes to mind. Forgetting a loved one's name, missing appointments or repeatedly misplacing everyday items are often considered ...
Jul 1, 2026
0
370
Lived experience is often dismissed—but we should recognize it as a form of expertise
Institutions increasingly invite people to contribute their lived experience. Government agencies appoint patients to advisory panels and call on communities for their views on policy. Health New Zealand employs peer support ...
Jul 1, 2026
0
2
